Home > Insider Trading > Filing (0001179110-20-010259)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-01	18,750	$0.00	45,170	No	4	M	Direct
Common Stock	Acquisiton	2020-10-02	3,125	$0.00	48,295	No	4	M	Direct
Common Stock	Disposition	2020-10-05	11,185	$71.24	37,110	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2020-10-01	18,750	$0.00	18,750	$0.00
Common Stock	Restricted Stock Unit	Disposition	2020-10-02	3,125	$0.00	3,125	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,750			No	4	M	Direct
28,125			No	4	M	Direct

Footnotes

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting October 2020.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
Represents the partial vesting and settlement of RSUs, starting January 2, 2020.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
On March 27, 2020, the Reporting Person was granted a RSU, which vests in three tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Issuer's stock price. On October 1, 2020, the Issuer's Board of Directors determined that the milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
The RSUs vest over four years. 25% of the RSUs vest on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.